3166-16-3Relevant academic research and scientific papers
High-Fidelity Dimerization of Xanthenyl Radicals and Dynamic Qualities of a Congested Ethane: Diethyl Dixanthenyl-9,9′-Dicarboxylate
Hogan, David T.,Dubrawski, Zachary,Gelfand, Benjamin S.,Sutherland, Todd C.
supporting information, (2021/12/23)
Exploration of the sterically-congested ethane diethyl dixanthenyl-9,9′-dicarboxylate has revealed the dynamic behavior arising from its congested C?C bond. Interlocking ‘geared’ substituents and favorable dispersion interactions around this bond result in a conformational preference for partially cofacial xanthene moieties both in solid state and as dilute solutions. The weak, centrally located C?C bond is 1.628 ? long and permits selective thermolysis to yield two carbon-centered ethyl xanthenyl-9-carboxylate radicals, which dimerize with high fidelity into the original sterically-congested ethane. Recombination of the radicals into this symmetrical head-to-head dimer is highly reproducible – by observing the equilibrium, the bond dissociation enthalpy was calculated to be 20.4 kcal ? mol?1. The substituents around the central carbon provide insufficient stabilization against oxygen, which consumes the radicals and unbalances the dimer-radical equilibrium.
Synthesis of oxidized thioxanthene-type base amplifiers and their application to photoreactive materials
Arimitsu, Koji,Kitamura, Hiroshi,Mizuochi, Ryuta,Furutani, Masahiro
, p. 309 - 311 (2015/03/30)
We propose base amplifiers (BAs) that are autocatalytically decomposed into base molecules by a small amount of trigger base molecules from photobase generators. We report here novel BAs having oxidized thioxanthene skeletons. It is confirmed that they are decomposed autocatalytically in solution or polymer matrix. They are applied to UV curing systems to improve their photosensitivity.
Spirotricyclic substituted azacycloalkane derivatives and uses thereof
-
, (2008/06/13)
Spirotricyclic azacycloalkyl compounds and pharmaceutically acceptable salts thereof are disclosed. The synthesis of these compounds is also described. One application of these compounds, which are alpha 1a adrenergic receptor antagonists, is in the treatment of benign prostatic hyperplasia. These compounds are selective in their ability to relax smooth muscle tissue enriched in the alpha 1a receptor subtype without at the same time inducing hypotension. One such tissue is found surrounding the urethral lining. Therefore, one utility of the instant compounds is to provide acute relief to males suffering from benign prostatic hyperplasia, by permitting less hindered urine flow. Another utility of the instant compounds is provided by combination with a human 5-alpha reductase inhibitory compound, such that both acute and chronic relief from the effects of benign prostatic hyperplasia can be achieved.
